Journal profile · Pathology
Pathobiology
ISSN 1015-2008 · eISSN 1423-0291 · S. Karger AG · SWITZERLAND · Bimonthly · Founded 1990
Pathobiology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 1.69; hybrid open access; median 147 days to acceptance (60 articles, last 24 months); community-reported acceptance: fairly easy; 37 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pathobiology is published by S. Karger AG and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Immune Cell Function and Interaction, together about 29.6% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Pathobiology offers a valuable platform for the publication of high-quality original research into the mechanisms underlying human disease. Aiming to serve as a bridge between basic biomedical research and clinical medicine, the journal welcomes articles from scientific areas such as pathology, oncology, microbiology, cell and molecular biology, and immunology.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Fernando C. SchmittPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance12.8%
- Human auditory perception and evaluationEngineering11.1%
- Immune Cell Function and InteractionImmunology and Microbiology5.7%
- Legal Cases and CommentaryMedicine4.6%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.4%
- Immune Response and InflammationImmunology and Microbiology4.3%
- Physics and Engineering Research ArticlesEngineering4.3%
- Cell Adhesion Molecules ResearchMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 3 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.69LetPub ·
- Impact factor (publisher)
- 1.7Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- CiteScore (publisher)
- 4.9Publisher website ·
- SJR 2026-06
- 0.72LetPub ·
- SNIP 2026-06
- 0.76LetPub ·
- h-index
- 48LetPub ·
- h-index
- 78OpenAlex ·
- i10-index
- 912OpenAlex ·
- 2-year mean citedness
- 1.51OpenAlex ·
- Self-citation rate
- 5.9%LetPub ·
- Share of gold OA articles
- 28.57%LetPub ·
Volume
- Articles per year
- 34LetPub ·
Articles by year OpenAlex count · 1,874 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 19 | 6 | 14 |
| 2025 | 37 | 17 | 57 |
| 2024 | 32 | 20 | 62 |
| 2023 | 50 | 28 | 254 |
| 2022 | 57 | 25 | 602 |
| 2021 | 57 | 19 | 497 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
147 daysMedian, submission to acceptance · P25–P75 95 days – 207 days
- Acceptance to online
- median 19 days (60 articles)
- Submission to online
- median 176 days
- Sample
- 60 articles with submission and acceptance dates (71 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- S. Karger AG
- Country or region
- SWITZERLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1990
- ISSN
- 1015-2008
- Electronic ISSN
- 1423-0291
- Latest issue on the website
- Volume 93, Issue 4 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Pathobiology
What CAS zone is Pathobiology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pathobiology is in Zone 3 of Medicine, and in Zone 3 of the minor category Cell Biology / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pathobiology?
The latest impact factor listed by LetPub is 1.69; CiteScore 4.9, h-index 78.
How long does peer review take at Pathobiology?
Based on the dates recorded on 60 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 147 days (interquartile range 95–207 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Pathobiology?
According to LetPub and DOAJ records, Pathobiology is indexed in SCIE and Scopus.
Is Pathobiology open access, and what is the APC?
Pathobiology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .